DiaSorin
€74.26Change from previous close: +0.35%Absolute change: +€0.26
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- €3.67B
- Enterprise value
- €4.5B
- P/E (trailing 12 months)
- 27.3
- Forward P/E
- 17.2
- PEG
- 1.63
- Price/book
- 2.58
- Price/sales
- 3.12
- EV/EBITDA
- 13.2
- EV/revenue
- 3.82
Profitability and growth
- Gross margin
- 64.5%
- Operating margin
- 22.4%
- Net margin
- 11.9%
- ROE
- 9.2%
- ROA
- 5.5%
- Revenue growth (year over year)
- 2.7%
- Earnings growth (year over year)
- 6.6%
Financial health
- Total cash
- €120.88M
- Total debt
- €965.25M
- Debt/equity
- 0.68
- Current ratio
- 1.79
- Quick ratio
- 0.85
Dividends
- Annual dividend per share
- €1.30
- Dividend yield
- 1.8%
- Payout ratio
- 47.8%
- Ex-dividend date
- May 18, 2026
Analysts and estimates
- Average price target
- €72.81
- Median price target
- €73.50
- High price target
- €90.00
- Low price target
- €55.00
- Analysts with a price target
- 14
- Forward EPS
- €4.32
- EPS estimate, current year
- €3.92
Shares and trading
- Beta
- 0.70
- Average volume
- 207.01K
- Shares outstanding
- 49.44M
- Float
- 14.96M
- Institutional ownership
- 13.7%
- Insider ownership
- 57.6%